115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of entrectinib in children withNTRK orros1 fusion-positive (fp) primary central nervous system (CNS) tumors
    Meeting Abstract

    Bagchi, A.; Robinson, G. W.; Desai, A. V.; Wu, Y.; Wang, H.; Basu, E. M.; Casanova, M.; van Tilburg, C. M.; Campbell-Hewson, Q.; Armstrong, A. E.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Distribution and clinical significance of FGFR alterations in pediatric and AYA gliomas
    Meeting Abstract

    Nobre, L.; Farouk, S.; Larsen, A.; Bennett, J.; Ho, I. C.; Siddaway, R.; Mellinghoff, I.; Perreault, S.; Magimairajan, V.; Larouche, V.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802)
    Meeting Abstract

    Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Pilot study to evaluate automated laboratory data transfer into Medidata Rave across the National Cancer Institute (NCI)-supported Pediatric Brain Tumor Consortium (PBTC) and Pediatric Early Phase Clinical Trial Network (PEP-CTN) cooperative groups
    Meeting Abstract

    Miler, T. P.; Aplenc, R.; Minard, C.; Lensing, S.; Wang, Y.; Velamuru, P.; Foster, J. H.; Silverman, M.; Sung, C.; Wong, K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Medical and surgical variables associated with relapse in central nervous system (CNS) nongerminomatous germ cell tumors (NGGCTS): Secondary analysis of stratum 1 of the Children's Oncology Group ACNS1123 phase 2 clinical trial
    Meeting Abstract

    Nagabushan, S.; Yan, R.; Lin, T.; Onar-Thomas, A.; Souweidane, M. M.; Dhall, G.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Lessons learned from longitudinal care in posterior fossa syndrome
    Meeting Abstract

    Tsetlina, V.; Cassidy, D.; Tenaglia, A. L.; Levin, J.; Tsao, E.; Ibanez, K.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Isocitrate dehydrogenase 1 inhibition primes group-3 medulloblastomas for cuproptosis
    Meeting Abstract

    Dang, D.; McKolay, J.; Smith, K.; Panwalkar, P.; Sweha, S.; Natarajan, S. K.; Pun, M. J.; Ji, S.; Patel, D.; Animasahun, O.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)
    Meeting Abstract

    Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save